HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Frequently ill child syndrome].

Abstract
The efficacy of cycloferon use in the treatment of frequently ill children (FIC) was estimated by the dynamics of the blood plasma proteomic profile. A group of FIC at the age of 4 to 10 years were observed. Cycloferon was administered according to the standard schemes. The results were analysed by the computer programme complex, including the anamnesis, clinical symptoms, infection index, findings of the electrophoretic and mass-spectrometric analyses of the blood plasma before and after the drug use. The intensity indices of the Rho and Ras proteins, the signal pathways, in the blood proteomic profile proved to be sensitive and specific parameters for estimating the regimens of the therapy and prophylaxis of respiratory tract infection in FIC. The epidemiologic efficacy of cycloferon, as an agent of nonspecific immunoprophylaxis for FIC during seasonal prevalence of respiratory tract infection and influenza cases was shown.
AuthorsM G Romantsov, I Iu Mel'nikova, I V Sarvilina
JournalAntibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] (Antibiot Khimioter) Vol. 57 Issue 9-10 Pg. 8-16 ( 2012) ISSN: 0235-2990 [Print] Russia (Federation)
PMID23477215 (Publication Type: Journal Article)
Chemical References
  • Acridines
  • Blood Proteins
  • Interferon Inducers
  • ras Proteins
  • rho GTP-Binding Proteins
  • 10-carboxymethyl-9-acridanone
Topics
  • Acridines (administration & dosage)
  • Blood Proteins (metabolism)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Influenza, Human (blood, drug therapy)
  • Interferon Inducers (administration & dosage, adverse effects)
  • Male
  • Proteomics (methods)
  • Signal Transduction (drug effects)
  • Syndrome
  • ras Proteins (metabolism)
  • rho GTP-Binding Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: